03 Mar 2022 by admin in UncategorizedComments NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
28 Feb 2022 by admin in UncategorizedComments Design Therapeutics Announces FDA Clearance of Investigational New Drug Application for First GeneTACTM Molecule for Friedreich Ataxia
16 Feb 2022 by admin in UncategorizedComments Walking Fish Therapeutics Closes $73 Million Series A Financing
08 Feb 2022 by admin in UncategorizedComments Arcellx Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
02 Feb 2022 by admin in UncategorizedComments Syros Receives FDA Orphan Drug Designation for Tamibarotene for the Treatment of MDS
01 Feb 2022 by admin in UncategorizedComments Design Therapeutics Appoints Drug Development Expert, Jae Kim, M.D., as Chief Medical Officer
28 Jan 2022 by admin in UncategorizedComments Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings
17 Jan 2022 by admin in UncategorizedComments Eluminex Biosciences Successfully Completes Its First Pre-IND Meeting with the United States Food and Drug Administration for a Multivalent Fc Fusion Protein (EB-101) for the Treatment of Neovascular Age-related Macular Degeneration
10 Jan 2022 by admin in UncategorizedComments Syros Announces Clinical Updates and 2022 Goals to Support its Advancement to a Fully Integrated Biopharmaceutical Company
10 Jan 2022 by admin in UncategorizedComments BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies
05 Jan 2022 by admin in UncategorizedComments Eluminex Further Expands Leadership Team and Receives New Awards
13 Dec 2021 by admin in UncategorizedComments RareStone Group & Rhythm Pharmaceuticals Announce Exclusive Licensing Agreement for the Development and Commercialization of IMCIVREE (setmelanotide) in China
12 Dec 2021 by admin in UncategorizedComments NextCure and Collaborators Provide Data on Targets in Development at American Society of Hematology Annual Meeting
10 Dec 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Closing of $100 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
09 Dec 2021 by admin in UncategorizedComments Interius BioTherapeutics Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform
07 Dec 2021 by admin in UncategorizedComments Alebund Pharmaceuticals Holds Groundbreaking Ceremony for Yangzhou Research and Production Base
06 Dec 2021 by admin in UncategorizedComments Innoforce Completes Second Tranche of Series A Financing
26 Nov 2021 by admin in UncategorizedComments Crescendo Biologics Wins “Best Established Biotech Company” at the 2021 OBN Awards
21 Nov 2021 by admin in UncategorizedComments Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor
18 Nov 2021 by admin in UncategorizedComments Tempest Announces First Patient Dosed with TPST-1495 in Combination with Pembrolizumab
18 Nov 2021 by admin in UncategorizedComments Syros Reports Third Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
18 Nov 2021 by admin in UncategorizedComments Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors
16 Nov 2021 by admin in UncategorizedComments KIRA PHARMACEUTICALS APPOINTS TERI LOXAM AS CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER
12 Nov 2021 by admin in UncategorizedComments Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
10 Nov 2021 by admin in UncategorizedComments Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights
10 Nov 2021 by admin in UncategorizedComments Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates
09 Nov 2021 by admin in UncategorizedComments Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
05 Nov 2021 by admin in UncategorizedComments Syros Reports Third Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
01 Nov 2021 by admin in UncategorizedComments Laronde Expands Board of Directors with Leading Pharmaceutical Executives
20 Oct 2021 by admin in UncategorizedComments Crescendo Biologics announces prestigious new collaboration with The Institute of Cancer Research, London
19 Oct 2021 by admin in UncategorizedComments NextCure Announces Three New Members of its Scientific Advisory Board
13 Oct 2021 by admin in UncategorizedComments Syros Reports Inducement Grant to Chief Financial Officer under Nasdaq Listing Rule 5635(c)(4)
13 Oct 2021 by admin in UncategorizedComments Eluminex Biosciences Announces the Grand Opening of New Global Headquarters and Research and Development Center in Suzhou
12 Oct 2021 by admin in UncategorizedComments Syros Pharmaceuticals Announces Appointment of Jason Haas as Chief Financial Officer
12 Oct 2021 by admin in UncategorizedComments Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer
07 Oct 2021 by admin in UncategorizedComments NextCure Announces Publication of Preclinical Data for NC410
05 Oct 2021 by admin in UncategorizedComments Pennovation Lab welcomes new tenant Interius BioTherapeutics to its innovation ecosystem
